Profile data is unavailable for this security.
About the company
Haw Par Corporation Limited is a Singapore-based holding company. The principal activities of the Company are licensing the Tiger trademarks and owning and holding investments for the long term. Its segments include Healthcare products, Investments and Others. Its Healthcare products segment is engaged in manufacturing and distributing topical analgesic products under the Tiger Balm and Kwan Loong brands. Its Investments segment is engaged in long-term investing activities, mainly in quoted securities in Asia. Its Others segment includes the property division, which owns and leases out several investment properties in Asia, and the leisure division, which provides family and tourist-oriented leisure activities in the form of oceanariums. Its Tiger Balm brand offers products such as Tiger Balm White Ointment, Tiger Balm Muscle Rub, Tiger Balm Back Pain Patch, and Tiger Balm Muscle Rub. Its Kwan Loong brand offers products such as Kwan Loong Medicated Oil and Kwan Loong Refresher.
- Revenue in SGD (TTM)253.05m
- Net income in SGD250.42m
- Incorporated1969
- Employees595.00
- LocationHaw Par Corporation Ltd401 Commonwealth Drive#03-03 Haw Par Techno Centre 149598SingaporeSGP
- Phone+65 63379102
- Fax+65 63369232
- Websitehttps://www.hawpar.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Resources Dubl-Crne Phrmctl Co Ltd | 2.02bn | 291.47m | 3.53bn | 13.41k | 12.00 | 1.69 | -- | 1.75 | 1.53 | 1.53 | 10.62 | 10.90 | 0.6524 | 2.99 | 5.05 | 816,058.20 | 9.70 | 8.90 | 13.45 | 11.99 | 56.61 | 57.39 | 14.86 | 13.13 | 1.75 | -- | 0.0904 | 33.53 | -0.8711 | 3.63 | -2.19 | 9.06 | 21.41 | 9.15 |
| Catalyst Pharmaceuticals Inc | 745.07m | 271.12m | 3.57bn | 182.00 | 13.70 | 2.96 | 11.18 | 4.79 | 1.68 | 1.68 | 4.63 | 7.79 | 0.6024 | 3.08 | 6.14 | 3,236,203.00 | 21.92 | 22.15 | 25.40 | 25.81 | 85.19 | 85.59 | 36.39 | 31.20 | 5.82 | -- | 0.00 | 0.00 | 19.78 | 37.68 | 30.78 | 23.37 | 38.45 | -- |
| BrightGene Bio-Medical Technology Co Ltd | 217.65m | 11.45m | 3.58bn | 1.15k | 307.59 | 7.92 | -- | 16.43 | 0.1489 | 0.1489 | 2.82 | 5.79 | 0.2305 | 1.61 | 3.38 | 1,025,174.00 | 0.5058 | 5.25 | 0.6383 | 6.47 | 51.53 | 56.22 | 2.19 | 17.55 | 0.9402 | 1.23 | 0.4935 | 21.32 | 8.74 | 20.58 | -6.57 | 11.23 | 23.50 | 3.20 |
| Twist Bioscience Corp | 495.32m | -96.88m | 3.64bn | 979.00 | -- | 6.30 | -- | 7.35 | -1.27 | -1.27 | 6.46 | 7.44 | 0.6282 | 6.71 | 8.76 | 399,956.10 | -12.29 | -24.09 | -13.97 | -26.80 | 51.62 | 43.29 | -19.56 | -67.76 | 3.37 | -- | 0.00 | -- | 20.32 | 33.11 | 62.79 | -- | 23.20 | -- |
| Hisamitsu Pharmaceutical Co Inc | 1.29bn | 162.03m | 3.67bn | 2.80k | 21.77 | 1.57 | 16.47 | 2.85 | 276.99 | 276.99 | 2,208.13 | 3,837.32 | 0.4704 | 2.64 | 3.42 | 56,901,390.00 | 6.04 | 4.34 | 7.25 | 4.99 | 59.05 | 57.83 | 12.84 | 10.32 | 3.28 | -- | 0.0086 | 50.29 | 10.09 | 2.04 | 55.76 | 3.08 | 29.89 | 0.7127 |
| Haw Par Corporation Ltd | 253.05m | 250.42m | 3.70bn | 595.00 | 14.77 | 0.9055 | 14.40 | 14.61 | 1.13 | 1.13 | 1.14 | 18.44 | 0.0631 | 5.15 | 4.88 | -- | 6.24 | 4.78 | 6.44 | 4.90 | 55.75 | 53.78 | 98.96 | 90.33 | 6.04 | -- | 0.0083 | 72.61 | 5.50 | 0.0685 | 5.40 | 4.61 | 3.11 | 5.92 |
| Shanghai Henlius Biotech Inc | 1.07bn | 152.44m | 3.75bn | 3.54k | 38.66 | 9.35 | 16.27 | 3.50 | 1.73 | 1.73 | 12.20 | 7.17 | 0.5386 | 1.73 | 5.86 | 1,886,295.00 | 7.66 | -3.21 | 13.85 | -5.76 | 75.77 | 72.50 | 14.22 | -7.87 | 0.5046 | 10.47 | 0.5185 | -- | 6.11 | 128.98 | 50.26 | -- | 10.83 | -- |
| Emcure Pharmaceuticals Ltd | 1.23bn | 120.83m | 3.83bn | 6.73k | 31.71 | -- | 21.22 | 3.12 | 45.91 | 45.91 | 467.02 | -- | -- | -- | -- | 13,148,240.00 | -- | 8.47 | -- | 15.86 | 59.93 | 59.30 | 10.11 | 8.99 | -- | 30.68 | -- | 0.00 | 18.59 | 9.36 | 36.76 | 52.13 | 21.35 | -- |
| Joincare Pharmaceutical Group Ind. Co. | 2.80bn | 252.00m | 3.87bn | 14.35k | 15.46 | 1.41 | -- | 1.38 | 0.7413 | 0.7413 | 8.24 | 8.13 | 0.4211 | 2.40 | 5.51 | 1,059,126.00 | 8.29 | 8.60 | 17.45 | 18.66 | 61.28 | 62.42 | 19.70 | 17.66 | 2.38 | -- | 0.1776 | 27.59 | -6.17 | 5.45 | -3.90 | 9.17 | 6.84 | 4.56 |
| Kalbe Farma Tbk PT | 2.59bn | 263.61m | 3.89bn | 12.78k | 14.36 | 2.17 | 11.80 | 1.50 | 76.62 | 76.62 | 754.10 | 507.01 | 1.17 | 3.08 | 6.47 | 2,664,288,000.00 | 12.05 | 12.17 | 15.24 | 15.15 | 39.50 | 40.06 | 10.31 | 10.97 | 2.36 | -- | 0.0206 | 52.79 | 7.16 | 7.59 | 17.13 | 5.27 | -8.81 | 12.47 |
| Holder | Shares | % Held |
|---|---|---|
| First Eagle Investment Management LLCas of 16 Jan 2026 | 19.80m | 8.95% |
| Kayne Anderson Rudnick Investment Management LLCas of 26 Feb 2025 | 11.02m | 4.98% |
| Dimensional Fund Advisors LPas of 31 Jan 2026 | 1.52m | 0.69% |
| WCM Investment Management LLCas of 31 Dec 2025 | 778.70k | 0.35% |
| State Board of Administration of Florida Retirement Systemas of 30 Sep 2025 | 724.30k | 0.33% |
| Smart Private Managers Luxembourg SAas of 31 Dec 2025 | 620.30k | 0.28% |
| First Sentier Investors (Singapore)as of 30 Sep 2025 | 399.10k | 0.18% |
| First Sentier Investors (Hong Kong) Ltd.as of 31 Oct 2025 | 235.30k | 0.11% |
| Dimensional Fund Advisors Ltd.as of 30 Nov 2025 | 173.28k | 0.08% |
| Value Intelligence Advisors GmbHas of 31 Oct 2025 | 101.20k | 0.05% |
